Therapeutic gene silencing in neurological disorders, using interfering RNA

Journal of Molecular Medicine

Volumn 83, Issue 6, 2005, Pages 413-419

  Ralph, G Scott ^a   Mazarakis, Nicholas D ^a   Azzouz, Mimoun ^a  

^a OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

Gene silencing; Gene therapy; Interfering RNA; Neurodegeneration; Viral vectors

Indexed keywords

LENTIVIRUS VECTOR; SMALL INTERFERING RNA; VIRUS VECTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DYSTONIA; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENE SILENCING; HUMAN; HUNTINGTON CHOREA; MEDICAL RESEARCH; NEUROLOGIC DISEASE; PARKINSON DISEASE; REVIEW; RNA INTERFERENCE; RNA SEQUENCE; RNA STABILITY; SPINAL MUSCULAR ATROPHY; SPINOCEREBELLAR DEGENERATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

AMYOTROPHIC LATERAL SCLEROSIS; GENE SILENCING; GENE THERAPY; HUMANS; NERVOUS SYSTEM DISEASES; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 21544444721     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0649-1     Document Type: Review

References (78)

1. Napoli C, Lemieux C, Jorgensen R (1990) Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell 2:279-289
2. van der Krol AR, Mur LA, Beld M, Mol JN, Stuitje AR (1990) Flavonoid genes in petunia: addition of a limited number of gene copies may lead to a suppression of gene expression. Plant Cell 2:291-299
3. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811
4. Zamore PD, Tuschl T, Sharp PA, Bartel DP (2000) RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101:25-33
5. Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15:188-200
6. Ui-Tei K, Zenno S, Miyata Y, Saigo K (2000) Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target. FEBS Lett 479:79-82
7. Caplen NJ, Fleenor J, Fire A, Morgan RA (2000) dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference. Gene 252: 95-105
8. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD (1998) How cells respond to interferons. Annu Rev Biochem 67:227-264
9. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498
10. Xia H, Mao Q, Paulson HL, Davidson BL (2002) siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20:1006-1010
11. Hasuwa H, Kaseda K, Einarsdottir T, Okabe M (2002) Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett 532:227-230
12. Paul CP, Good PD, Winer I, Engelke DR (2002) Effective expression of small interfering RNA in human cells. Nat Biotechnol 20:505-508
13. Carmell MA, Zhang L, Conklin DS, Hannon GJ, Rosenquist TA (2003) Germline transmission of RNAi in mice. Nat Struct Biol 10:91-92
14. Novina CD, Sharp PA (2004) The RNAi revolution. Nature 430:161-164
15. Bernstein E, Caudy AA, Hammond SM, Hannon GJ (2001) Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409:363-366
16. Hammond SM, Bernstein E, Beach D, Hannon GJ (2000) An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404:293-296
17. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T (2002) Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110:563-574
18. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
19. Krichevsky AM, Kosik KS (2002) RNAi functions in cultured mammalian neurons. Proc Natl Acad Sci USA 99:11926-11929
20. Blander G, de Oliveira RM, Conboy CM, Haigis M, Guarente L (2003) Superoxide dismutase 1 knock-down induces senescence in human fibroblasts. J Biol Chem 278:38966-38969
21. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553
22. Miyagishi M, Taira K (2002) U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 20:497-500
23. Rubinson DA, Dillon CP, Kwiatkowski AV, et al (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33:401-406
24. Barton GM, Medzhitov R (2002) Retroviral delivery of small interfering RNA into primary cells. Proc Natl Acad Sci USA 99:14943-14945
25. Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ (2003) Local gene knockdown in the brain using viral-mediated RNA interference. Nat Med 9:1539-1544
26. Tiscornia G, Singer O, Ikawa M, Verma IM (2003) A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 100:1844-1848
27. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22:326-330
28. Gong D, Ferrell JE Jr (2004) Picking a winner: new mechanistic insights into the design of effective siRNAs. Trends Biotechnol 22:451-454
29. Jackson AL, Bartz SR, Schelter J, et al (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635-637
30. Doench JG, Petersen CP, Sharp PA (2003) siRNAs can function as miRNAs. Genes Dev 17:438-442
31. Zeng Y, Yi R, Cullen BR (2003) MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 100:9779-9784
32. Saxena S, Jonsson ZO, Dutta A (2003) Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J Biol Chem 278:44312-44319
33. Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R (2003) Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet 34:263-264
34. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5:834-839
35. Moss EG, Taylor JM (2003) Small-interfering RNAs in the radar of the interferon system. Nat Cell Biol 5:771-772
36. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H (2002) Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 32:107-108
37. Sorensen DR, Leirdal M, Sioud M (2003) Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 327:761-766
38. Soutschek J, Akinc A, Bramlage B, et al (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432:173-178
39. Zhao LJ, Jian H, Zhu H (2003) Specific gene inhibition by adenovirus-mediated expression of small interfering RNA. Gene 316:137-141
40. Miyagishi M, Taira K (2002) Development and application of siRNA expression vector. Nucleic Acids Res Suppl:113-114
41. Wiznerowicz M, Trono D (2003) Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 77:8957-8961
42. Hosono T, Mizuguchi H, Katayama K, et al (2004) Adenovirus vector-mediated doxycycline-inducible RNA interference. Hum Gene Ther 15:813-819
43. Martin-Rendon E, Azzouz M, Mazarakis ND (2001) Lentiviral vectors for the treatment of neurodegenerative diseases. Curr Opin Mol Ther 3:476-481
44. Blomer U, Ganser A, Scherr M (2002) Invasive drug delivery. Adv Exp Med Biol 513:431-451
45. Rosen DR, Siddique T, Patterson D, et al (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62
46. Deng HX, Hentati A, Tainer JA, et al (1993) Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261:1047-1051
47. Gurney ME, Pu H, Chiu AY, et al (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264:1772-1775
48. Ding H, Schwarz DS, Keene A, et al (2003) Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2:209-217
49. Maxwell MM, Pasinelli P, Kazantsev AG, Brown RH Jr (2004) RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells. Proc Natl Acad Sci USA 101:3178-3183
50. Bruijn LI, Becher MW, Lee MK, et al (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-338
51. Wong PC, Pardo CA, Borchelt DR, et al (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105-1116
52. Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH (2003) Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301:839-842
53. Azzouz M, Ralph GS, Storkebaum E, et al (2004) VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429:413-417
54. Michalik A, Van Broeckhoven C (2003) Pathogenesis of polyglutamine disorders: aggregation revisited. Hum Mol Genet 12 Spec No 2:R173-R186
55. Young AB (2003) Huntingtin in health and disease. J Clin Invest 111:299-302
56. Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101:57-66
57. Caplen NJ, Taylor JP, Statham VS, Tanaka F, Fire A, Morgan RA (2002) Rescue of polyglutamine-mediated cytotoxicity by double-stranded RNA-mediated RNA interference. Hum Mol Genet 11:175-184
58. Miller VM, Xia H, Marrs GL, et al (2003) Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 100:7195-7200
59. Orr HT, Chung MY, Banfi S, et al (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 4:221-226
60. Xia H, Mao Q, Eliason SL, et al (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10:1006-1010
61. Okada T, Nomoto T, Shimazaki K, et al (2002) Adeno-associated virus vectors for gene transfer to the brain. Methods 28:237-247
62. Azzouz M, Kingsman SM, Mazarakis ND (2004) Lentiviral vectors for treating and modeling human CNS disorders. J Gene Med 6:951-962
63. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839-840
64. Vila M, Przedborski S (2004) Genetic clues to the pathogenesis of Parkinson's disease. Nat Med 10[Suppl]:S58-S62
65. Paisan-Ruiz C, Jain S, Evans EW, et al (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's Disease. Neuron 44:595-600
66. Zimprich A, Biskup S, Leitner P, et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601-607
67. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356
68. Miller VM, Gouvion CM, Davidson BL, Paulson HL (2004) Targeting Alzheimer's disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res 32:661-668
69. Lewis J, Dickson DW, Lin WL, et al (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487-1491
70. Oddo S, Caccamo A, Shepherd JD, et al (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39:409-421
71. Kao SC, Krichevsky AM, Kosik KS, Tsai LH (2004) BACE1 suppression by RNA interference in primary cortical neurons. J Biol Chem 279:1942-1949
72. Yan R, Bienkowski MJ, Shuck ME, et al (1999) Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity. Nature 402:533-537
73. Vassar R, Bennett BD, Babu-Khan S, et al (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735-741
74. Sisodia SS, St George-Hyslop PH (2002) Gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci 3:281-290
75. Wong GT, Manfra D, Poulet FM, et al (2004) Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation. J Biol Chem 279:12876-12882
76. Roberds SL, Anderson J, Basi G, et al (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 10:1317-1324
77. Ohm TG, Glockner F, Distl R, Treiber-Held S, Meske V, Schonheit B (2003) Plasticity and the spread of Alzheimer's disease-like changes. Neurochem Res 28:1715-1723
78. Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP (2001) Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 114:1179-1187